Literature DB >> 12434465

Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.

Tammy Baltic1, Evelyn Schlosser, Marilyn Kay Bedell.   

Abstract

Neutropenic fever is an oncologic emergency that requires prompt assessment and treatment with antibiotics. Although the term "prompt" is not defined in numbers of minutes in the biomedical literature, the literature does indicate that the sooner antibiotics are initiated, the greater the likelihood of a positive clinical outcome. At Dartmouth-Hitchcock Medical Center in Lebanon, NH, the oncology team was concerned about the length of time before adult inpatients with febrile neutropenia received their initial dose of antibiotics (cycle time). The purpose of this quality improvement project was to reduce treatment delays in patients with febrile neutropenia. A multidisciplinary team charted the existing admission process and identified three areas for improvement: (a) inpatient orders, (b) the admission communication process, and (c) multidisciplinary staff accountability. Following implementation, the hematology and oncology clinical nurse specialist completed a chart review of all patients with febrile neutropenia, which revealed a nearly 50% reduction in cycle time on the inpatient unit.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434465     DOI: 10.1188/02.CJON.337-340

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  6 in total

1.  Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis.

Authors:  D Szwajcer; P Czaykowski; D Turner
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Management of fever and neutropenia in children with cancer.

Authors:  A Vedi; V Pennington; M O'Meara; K Stark; A Senner; P Hunstead; K Adnum; W Londall; L Maurice; Claire Wakefield; R J Cohn
Journal:  Support Care Cancer       Date:  2014-12-23       Impact factor: 3.603

3.  Improving hospital performance in the treatment of febrile neutropenia.

Authors:  Barry Meisenberg; Jan Clemons; John Ness; Nancy Faust; Mary Clance
Journal:  Support Care Cancer       Date:  2014-08-09       Impact factor: 3.603

4.  Time to antibiotic administration in children with febrile neutropenia: Report from a low middle-income country.

Authors:  Namrata Todurkar; Amita Trehan; Deepak Bansal
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 5.274

5.  Time to antibiotics and outcomes in cancer patients with febrile neutropenia.

Authors:  Thomas Perron; Mohamed Emara; Shahid Ahmed
Journal:  BMC Health Serv Res       Date:  2014-04-10       Impact factor: 2.655

6.  Successful emergency department interventions that reduce time to antibiotics in febrile pediatric cancer patients.

Authors:  Sandra Spencer; MIchele Nypaver; Katherine Hebert; Christopher Benner; Rachel Stanley; Daniel Cohen; Alexander Rogers; Jason Goldstick; Prashant Mahajan
Journal:  BMJ Qual Improv Rep       Date:  2017-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.